Patent grants in US as Elasmogen moves closer to commercialization and clinical development.

Stanford University announced Jan. 29 that it has received a grant from the Bill & Melinda Gates Foundation to accelerate efforts in vaccine development. The $50 million grant over 10 years will build on existing technology developed at Stanford and housed in the Human Immune Monitoring Core, and will establish the Stanford Human Systems Immunology Center. The center aims to better understand how the immune system can be harnessed to develop vaccines for the world's most deadly infectious diseases.

Enzymes are catalysts that speed up chemical reactions in living organisms and control many cellular biological processes by converting a molecule, or substrate, into a product used by the cell. For scientists, understanding details of how enzymes work is essential to the discovery of drugs to cure diseases and treat disorders.

Sigma-Aldrich issues second annual "State of Translational Research Survey Report", conducted in collaboration with the American Association for the Advancement of Science (AAAS) and the Academic Drug Discovery Consortium (ADDC).

Study indicates target for future drugs for measles, Ebola, RSV.

One of the most mysterious forms of life may turn out to be a rich and untapped source of antibacterial drugs.

The new method lets researchers identify weak and previously undetectable interactions between proteins inside living cells.

The custom technologies arm of Molecular Devices, a leader in bioanalytical systems for drug discovery, life science research, and bioassay development, has partnered with the Discovery Technologies team at the Roche Innovation Center Basel of Pharma Research and Early Development (pRED) to develop a high-throughput detection system for drug discovery screens employing Roche’s proprietary Ruthenium-based nanosecond time resolved fluorescence (Nano-TRF®) assays. The pRED screening teams in Basel and Shanghai are now installing the custom-developed Nano-TRF® cartridge in their existing Molecular Devices SpectraMax® Paradigm® multimode microplate readers and will receive on-demand delivery of new cartridges and continuing global technical support.

A new technique makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine, representing a potential tool for clinicians and law enforcement.

This is the inescapable conclusion of Michael Kinch’s adventures in data mining